Latest Enzymatica News & Updates

See the latest news and media coverage for Enzymatica. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Enzymatica

Developer of enzyme-based viral infection defenses

enzymatica.com
Headquarters
Lund, Sweden
Founded year
2006
Company type
Public company
Number of employees
25–50

Last updated

Latest news about Enzymatica

In short: Enzymatica appointed Sana Alajmovic as CEO and signed a major partnership with STADA to expand ColdZyme distribution in Germany and Austria.

Company announcements

  • Enzymatica

    Enzymatica holds annual general meeting

    Resolutions include adopting financial statements, no dividend, board re-elections, auditor appointment, remuneration, and share issue authorization.

  • Enzymatica

    Enzymatica’s CEO Sana Alajmovic discusses growth phase

    She highlights scientific foundation, ColdZyme technology, international expansion, partnerships, and brand strengthening. The interview is with Redeye.

  • Enzymatica

    Enzymatica announces Q1 2026 quarterly report

    Net sales are SEK 11.4 million. Partnership with STADA launches ColdZyme in Germany and Austria.

  • Enzymatica

    Enzymatica signs partnership with STADA for Germany and Austria

    The agreement covers launch and distribution of ColdZyme oral spray. Commercial impact starts from 2026/2027 cold season via STADA's platform.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Enzymatica

Track Enzymatica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.